SCHEMBL9435958

SCHEMBL9435958

CC(C)NC(=O)Nc1ccc(N(C)C)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.58
RAB9A P51151 6/20 0.58
NOX1 Q9Y5S8 5/20 0.58
SMN1; SMN2 Q16637 5/20 0.58
NPC1 O15118 4/20 0.58
TP53 P04637 3/20 0.58
ESR2 Q92731 1/20 0.58
CA12 O43570 2/20 0.57
CA1 P00915 2/20 0.57
CA2 P00918 2/20 0.57
CA9 Q16790 2/20 0.57
EPHX1 P07099 1/20 0.56
KMT2A Q03164 4/20 0.54
LMNA P02545 3/20 0.53
MEN1 O00255 2/20 0.53
L3MBTL1 Q9Y468 2/20 0.53
TSHR P16473 1/20 0.53
NFKB1 P19838 1/20 0.53
NFKB2 Q00653 1/20 0.53
RELA Q04206 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14359085 0.91 MAPT (0.50) MAPTRAB9ANOX1SMN1; SMN2NPC1
SCHEMBL14359082 0.91 MAPT (0.50) MAPTRAB9ANOX1SMN1; SMN2NPC1
SCHEMBL13449739 0.87 CA12 (0.70) RAB9ASMN1; SMN2CA12CA1CA2
SCHEMBL29663991 0.85 RAB9A (0.76) MAPTRAB9ANOX1SMN1; SMN2NPC1
SCHEMBL10781897 0.80 CA12 (0.57) MAPTRAB9ANOX1SMN1; SMN2NPC1
SCHEMBL24894114 0.79 CA12 (0.62) MAPTRAB9ASMN1; SMN2NPC1TP53
SCHEMBL5851828 0.79 CA12 (0.62) MAPTRAB9ASMN1; SMN2NPC1TP53
SCHEMBL13466499 0.79 CA12 (0.62) RAB9ASMN1; SMN2CA12CA1CA2
SCHEMBL3221296 0.79 MAPT (0.64) MAPTRAB9ANOX1SMN1; SMN2NPC1
SCHEMBL11913008 0.78 RAB9A (0.67) MAPTRAB9ASMN1; SMN2CA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4249480-A1 DIPHENYLPYRAZOLE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Northwest A&F University (CN) 2023-09-27 EP disclosed
US-20080293712-A1 Benzo[C][2,7]Naphtyridine Derivatives, Methods of Making Thereof and Methods of Use Thereof WYETH (US) 2008-11-27 US disclosed
US-5283362-A Reacting with an amine, terminating the reaction before the formation of by-product CHEMIE LINZ GESELLSCHAFT M.B.H. (AT) 1994-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080293712-A1 Benzo[C][2,7]Naphtyridine Derivatives, Methods of Making Thereof and Methods of Use Thereof PDPK1, PDK2, PDK3 MAPT 4382/4885RAB9A 1685/4885NOX1 922/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.